Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (111-120 of 517) with videos related to

Pageof 52
Sort By:
Head & Neck|March 11, 2008
Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 casesGideon Bachar, David Goldstein, Dale Brown, et al.
Head & Neck|August 16, 2008
Mucosal melanomas of the head and neck: experience of the Princess Margaret HospitalGideon Bachar, Kwok Seng Loh, Brian O'Sullivan, et al.
Radiation Oncology (London, England)|August 13, 2011
Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29Junjie Peng, Debing Shi, Karyn A Goodman, et al.
The Journal of Pain|July 21, 2019
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated PatientsHannah C Timmins, Tiffany Li, Matthew C Kiernan, et al.
International Journal of Molecular Sciences|December 4, 2020
Targeting HGF/c-MET Axis in Pancreatic CancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancerMichala Short, David Goldstein, Georgia Halkett, et al.
Asia-Pacific Journal of Clinical Oncology|January 21, 2020
Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groupsBee Teng Lim, Phyllis Butow, Ming Lo Sze, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 31, 2020
Recommendations from the Canadian Association of Head and Neck Surgical Oncology for the Management of Head and Neck Cancers during the COVID-19 pandemicDaniel A O'Connell, Hadi Seikaly, Andre Isaac, et al.
Clinical Colorectal Cancer|January 24, 2007
Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil countMichael Michael, David Goldstein, Stephen J Clarke, et al.
The Lancet. Oncology|September 1, 2005
Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumourFlorian Grimpen, Desmond Yip, Grant McArthur, et al.
Pageof 52

Showing results (111-120 of 517) with videos related to

Sort By:
Pageof 52
Head & Neck|March 11, 2008
Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 casesGideon Bachar, David Goldstein, Dale Brown, et al.
Head & Neck|August 16, 2008
Mucosal melanomas of the head and neck: experience of the Princess Margaret HospitalGideon Bachar, Kwok Seng Loh, Brian O'Sullivan, et al.
Radiation Oncology (London, England)|August 13, 2011
Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29Junjie Peng, Debing Shi, Karyn A Goodman, et al.
The Journal of Pain|July 21, 2019
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated PatientsHannah C Timmins, Tiffany Li, Matthew C Kiernan, et al.
International Journal of Molecular Sciences|December 4, 2020
Targeting HGF/c-MET Axis in Pancreatic CancerSrinivasa P Pothula, Zhihong Xu, David Goldstein, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancerMichala Short, David Goldstein, Georgia Halkett, et al.
Asia-Pacific Journal of Clinical Oncology|January 21, 2020
Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groupsBee Teng Lim, Phyllis Butow, Ming Lo Sze, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|July 31, 2020
Recommendations from the Canadian Association of Head and Neck Surgical Oncology for the Management of Head and Neck Cancers during the COVID-19 pandemicDaniel A O'Connell, Hadi Seikaly, Andre Isaac, et al.
Clinical Colorectal Cancer|January 24, 2007
Prognostic factors predictive of response and survival to a modified FOLFOX regimen: importance of an increased neutrophil countMichael Michael, David Goldstein, Stephen J Clarke, et al.
The Lancet. Oncology|September 1, 2005
Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumourFlorian Grimpen, Desmond Yip, Grant McArthur, et al.
Pageof 52